SEC Form 4 · accession 0001569769-26-000004
Summit Therapeutics Inc. · SMMT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Manmeet Singh Soni
Officer — COO and CFO · Director
Period of report
Jun 4, 2026
Accepted (ET)
Jun 4, 2026 · 4:40 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001599298
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 4, 2026 | P | 25,000 | $14.46 | A | 3,098,603 | D | |
| Common Stock | Jun 4, 2026 | P | 25,000 | $14.43 | A | 3,123,603 | D |
Table II — derivative securities
No Table II lines on this filing.